327 related articles for article (PubMed ID: 28214948)
1. Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial.
Oskarsdóttir AR; Gudmundsdottir BR; Indridason OS; Lund SH; Arnar DO; Bjornsson ES; Magnusson MK; Jensdottir HM; Vidarsson B; Francis CW; Onundarson PT
J Thromb Thrombolysis; 2017 May; 43(4):550-561. PubMed ID: 28214948
[TBL] [Abstract][Full Text] [Related]
2. Ignoring instead of chasing after coagulation factor VII during warfarin management: an interrupted time series study.
Oskarsdottir AR; Gudmundsdottir BR; Jensdottir HM; Flygenring B; Palsson R; Onundarson PT
Blood; 2021 May; 137(20):2745-2755. PubMed ID: 33512454
[TBL] [Abstract][Full Text] [Related]
3. Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.
Onundarson PT; Francis CW; Indridason OS; Arnar DO; Bjornsson ES; Magnusson MK; Juliusson SJ; Jensdottir HM; Vidarsson B; Gunnarsson PS; Lund SH; Gudmundsdottir BR
Lancet Haematol; 2015 Jun; 2(6):e231-40. PubMed ID: 26688233
[TBL] [Abstract][Full Text] [Related]
4. During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time.
Jonsson PI; Letertre L; Juliusson SJ; Gudmundsdottir BR; Francis CW; Onundarson PT
J Thromb Haemost; 2017 Jan; 15(1):131-139. PubMed ID: 27774726
[TBL] [Abstract][Full Text] [Related]
5. Fiix-prothrombin time monitoring improves warfarin anticoagulation outcome in atrial fibrillation: a systematic review of randomized trials comparing Fiix-warfarin or direct oral anticoagulants to standard PT-warfarin.
Onundarson PT; Arnar DO; Lund SH; Gudmundsdottir BR; Francis CW; Indridason OS
Int J Lab Hematol; 2016 May; 38 Suppl 1():78-90. PubMed ID: 27426862
[TBL] [Abstract][Full Text] [Related]
6. The need for an adapted initiation nomogram during Fiix prothrombin time monitoring of warfarin.
Onundarson PT; Gudmundsdottir BR
J Thromb Thrombolysis; 2019 Nov; 48(4):685-689. PubMed ID: 31401717
[TBL] [Abstract][Full Text] [Related]
7. Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time.
Gudmundsdottir BR; Francis CW; Bjornsdottir AM; Nellbring M; Onundarson PT
Thromb Res; 2012 Oct; 130(4):674-81. PubMed ID: 22225856
[TBL] [Abstract][Full Text] [Related]
8. Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article.
Onundarson PT; Palsson R; Witt DM; Gudmundsdottir BR
Thromb J; 2021 Oct; 19(1):72. PubMed ID: 34654442
[TBL] [Abstract][Full Text] [Related]
9. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of protocol-based pharmacotherapy management on anticoagulation with warfarin for patients with cardiovascular surgery.
Katada Y; Nakagawa S; Minakata K; Odaka M; Taue H; Sato Y; Yonezawa A; Kayano Y; Yano I; Nakatsu T; Sakamoto K; Uehara K; Sakaguchi H; Yamazaki K; Minatoya K; Sakata R; Matsubara K
J Clin Pharm Ther; 2017 Oct; 42(5):591-597. PubMed ID: 28503837
[TBL] [Abstract][Full Text] [Related]
11. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
Poon IO; Lal L; Brown EN; Braun UK
J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
[TBL] [Abstract][Full Text] [Related]
12. Low dose oral anticoagulation therapy in Chinese children with congenital heart disease.
Cheung YF; Leung MP
J Paediatr Child Health; 1998 Dec; 34(6):563-7. PubMed ID: 9928651
[TBL] [Abstract][Full Text] [Related]
13. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
[TBL] [Abstract][Full Text] [Related]
14. Home prothrombin time monitoring: a literature analysis.
Yang DT; Robetorye RS; Rodgers GM
Am J Hematol; 2004 Oct; 77(2):177-86. PubMed ID: 15389909
[TBL] [Abstract][Full Text] [Related]
15. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
Larson BJ; Zumberg MS; Kitchens CS
Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
[TBL] [Abstract][Full Text] [Related]
16. Management of oral anticoagulant treatment in patients with venous thromboembolism.
Pengo V
Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
[TBL] [Abstract][Full Text] [Related]
17. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR.
Sandén P; Renlund H; Svensson PJ; Själander A
Thromb Haemost; 2017 Jan; 117(1):27-32. PubMed ID: 27652593
[TBL] [Abstract][Full Text] [Related]
18. Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin.
Vijenthira A; Le Gal G; Castellucci LA; Carrier M
Thromb Res; 2014 Sep; 134(3):584-6. PubMed ID: 25037497
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
[TBL] [Abstract][Full Text] [Related]
20. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.
Schulman S; Parpia S; Stewart C; Rudd-Scott L; Julian JA; Levine M
Ann Intern Med; 2011 Nov; 155(10):653-9, W201-3. PubMed ID: 22084331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
